Patient-Reported Satisfaction With Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results From ALLEGRO-2b/3

June 2024 in “ Dermatology ”

Rodney Sinclair, Ernest H. Law, Xingqi Zhang, Fan Zhang, Lynne Napatalung, Samuel H. Zwillich, Brett King, Natasha Atanaskova Mesinkovska

ritlecitinib alopecia areata hair regrowth scalp hair growth

In the study "Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3," patients receiving active doses of ritlecitinib reported higher satisfaction with hair growth compared to those receiving a placebo, with results observed up to week 48. There was a strong agreement between the improvement in scalp hair growth as evaluated by clinicians and the satisfaction reported by patients, indicating that ritlecitinib may be an effective treatment for hair regrowth in individuals with alopecia areata.

View this study on escholarship.org →

Discuss this study in the Community →

Research cited in this study

17 / 17 results

research Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial

227 citations , April 2023 in “The Lancet”

The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata

research The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata

4 citations , March 2022 in “Dermatology and Therapy”

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

research Two Phase 3 Trials of Baricitinib for Alopecia Areata

148 citations , March 2022 in “The New England Journal of Medicine”

Baricitinib was effective in treating alopecia areata in two major trials.

research Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review

67 citations , March 2021 in “Dermatology and Therapy”

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan

research Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan

7 citations , January 2021 in “Dermatology and therapy”

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

research The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms

3 citations , October 2020 in “Journal of Investigative Dermatology Symposium Proceedings”

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

‘You Lose Your Hair, What’s the Big Deal?’ I Was So Embarrassed, I Was So Self-Conscious, I Was So Depressed: A Qualitative Interview Study to Understand the Psychosocial Burden of Alopecia Areata

research ‘You Lose Your Hair, What’s the Big Deal?’ I Was So Embarrassed, I Was So Self-Conscious, I Was So Depressed: A Qualitative Interview Study to Understand the Psychosocial Burden of Alopecia Areata

30 citations , September 2020 in “Journal of Patient-Reported Outcomes”

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

research Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata

134 citations , July 2020 in “Experimental dermatology”

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

research Emerging Topical and Systemic JAK Inhibitors in Dermatology

277 citations , December 2019 in “Frontiers in Immunology”

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

research Targeting the Janus Kinase Family in Autoimmune Skin Diseases

124 citations , October 2019 in “Frontiers in Immunology”

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

research Role of Janus Kinase Inhibitors in the Treatment of Alopecia Areata

53 citations , July 2018 in “Drug design, development and therapy”

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

research Multiplex Matrix Network Analysis of Protein Complexes in the Human TCR Signalosome

32 citations , August 2016 in “Science Signaling”

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

research The Autoimmune Basis of Alopecia Areata: A Comprehensive Review

162 citations , October 2014 in “Autoimmunity reviews”

Alopecia areata is caused by the immune system attacking hair follicles.

research Alteration in Hair Texture Following Regrowth in Alopecia Areata

7 citations , July 2011 in “Archives of Dermatology”

Alopecia areata caused a boy's hair to regrow straight instead of curly, but the exact reason is unknown.

research A Case of Widespread Non-Pigmented Hair Regrowth in Diffuse Alopecia Areata

21 citations , October 2007 in “Australasian Journal of Dermatology”

A woman with hair loss regrew white hair after taking prednisolone.

research Lymphocytes, Neuropeptides, And Genes Involved In Alopecia Areata

286 citations , August 2007 in “Journal of Clinical Investigation”

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

research Persistent Depigmented Regrowth After Alopecia Areata

23 citations , April 2002 in “Journal of the American Academy of Dermatology”

Depigmented hair regrowth after alopecia areata can be permanent.

Related Research

3 / 3 results

research Revitalizing Hair Growth: A New Regimen Utilizing Growth Factor Concentrate for Hair Loss Treatment

June 2024 in “Cureus”

GFC injections significantly improved hair growth and quality with minimal side effects.

research Alopecia Areata: A Multifactorial Autoimmune Condition

148 citations , December 2018 in “Journal of autoimmunity”

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

research Treating Resistant Cases of Alopecia Universalis

May 2018 in “Journal of cosmetology & trichology”

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.